Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials.
about
Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcomePharmacological treatments for preventing epilepsy following traumatic head injuryPharmacological treatments for preventing epilepsy following traumatic head injuryPosttraumatic epilepsy: a major problem in desperate need of major advancesDepression, stress, epilepsy and adult neurogenesisEpilepsy after head injuryRole of Anticonvulsants in the Management of Posttraumatic Epilepsy.Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammationOxidative stress and epilepsy: literature reviewTraumatic brain injury: risks of epilepsy and implications for medicolegal assessmentAnti-epileptogenic clinical trial designs in epilepsy: issues and optionsRapamycin attenuates the development of posttraumatic epilepsy in a mouse model of traumatic brain injuryPoststroke epilepsy: update and future directionsPathophysiology and clinical management of moderate and severe traumatic brain injury in the ICUVigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complexCritical decision making in severe head injury managementEarly Posttraumatic Seizures in the Pediatric Population.Pursuing paradoxical proconvulsant prophylaxis for epileptogenesisHippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures.ADC mapping and T1-weighted signal changes on post-injury MRI predict seizure susceptibility after experimental traumatic brain injury.Astrocyte-neuronal interactions in epileptogenesis.Antiepileptogenesis Therapy with Levetiracetam: Data from Kindling versus Status Epilepticus Models.Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus.KB-R7943 reduces 4-aminopyridine-induced epileptiform activity in adult rats after neuronal damage induced by neonatal monosodium glutamate treatment.Epileptogenesis in the immature brain: emerging mechanisms.Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug DevelopmentDeveloping Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway.ECoG studies of valproate, carbamazepine and halothane in frontal-lobe epilepsy induced by head injury in the ratIs refractory epilepsy preventable?Minozac treatment prevents increased seizure susceptibility in a mouse "two-hit" model of closed skull traumatic brain injury and electroconvulsive shock-induced seizures.Disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis.The natural history of epilepsy: an epidemiological view.Comparing drug treatments in epilepsy.Treating epilepsy across its different stages.Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsiesPediatric posttraumatic seizures: epidemiology, putative mechanisms of epileptogenesis and promising investigational progress.Post-traumatic seizure disorder following acquired brain injury.Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis.Cost-effectiveness analysis of intravenous levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injury
P2860
Q21032453-9FC1F300-FB0F-46D2-BE9A-C529F63545E3Q24187948-70E2F50E-E232-40E6-AC58-88C05892C86DQ24202936-6D5DBACE-2675-4906-9493-DCBFD235AC1AQ24537775-8209FF52-DF47-47B8-B796-4839F9A91903Q24634793-BABBA72F-651D-44D5-A6DF-1B2CE745DB16Q24655908-61D31786-506C-4FB1-8B20-4A38EED0E0F8Q26752356-0923025F-88C7-483D-9193-7384D7C43EC2Q26823386-36969CAB-426F-4A38-B010-B00228CCD8FBQ26996304-0158AAFF-C6C9-4CB1-9B02-F107297581A9Q27025356-8D7FD50A-F390-4E93-82EC-00677B43CFAEQ27027689-0EB315C5-557E-4697-A74D-0F528A6F9ACFQ27319659-78FCFD96-A2D5-49D5-98BD-3BC10B4A3CC1Q28071350-A304AE35-80C6-4215-AD35-C397DB102814Q28082064-E7E8E7CB-10D9-40F1-96AF-6BC56090ACAEQ28486250-8032BF5E-CE00-4C4A-BDE8-BFB69FA099D6Q29014208-0F771CC0-9B49-492B-B875-61C14305BF90Q30300999-E6DCDC0A-0C44-487A-9221-396E07B2D554Q30495206-32A4F7C2-8B29-4CFD-BB0C-856E561727EAQ30497503-17414924-9E56-49AF-8FD9-5DE6AB29E592Q30672994-AAED72F3-9BF3-44D8-9020-476D3B3F14EDQ30911884-8FA6AFC3-0EDF-405B-B58A-CC295E2D99B2Q31146232-F4310358-B9D4-4644-9AA9-109C38FEC357Q33620044-F4BCAA98-6441-4791-8501-DF5B8DAF0A1AQ33651868-4C2682C5-6DEE-4292-BF85-5FE09FDF2F98Q33656567-EC6D5F0D-4239-4C52-9A3B-5CA6770C0FC8Q33677979-7C000D84-6E91-4980-94B3-791AEBABA869Q33805859-AFB78037-3633-4751-AD08-EE067743CFBDQ34005340-5BBBF0F7-E986-4A88-A923-1FDDE63F7990Q34123660-AED9F736-1B03-4F0D-9E11-A6DF3D5ED1D0Q34142445-1597F6B6-62FB-4B35-B0EA-A3FA177519EBQ34238657-0EFB1305-F17C-469E-BBFE-D678B76FB214Q34349568-E789BA94-8A49-49F2-BF8D-280A68ED3DDAQ34409373-D994D9D0-E4A2-4202-B994-8844DD8A6F54Q34409465-4E9739EE-70DF-459F-9F64-E1CD104BE645Q34458158-F9433EA5-F1DC-4AB8-8811-DBDABC55812FQ34498303-BED8086B-A7FB-4374-AF42-FDB0BE55D990Q34562044-369A50F0-5B53-4CE1-BA4A-DA02FD99DACCQ34609112-3896F2AD-18F2-4F67-8597-AFB988E3E789Q35028378-385132E4-D947-4B9E-A52B-049A5D7F43A1Q35205335-440D1A1D-E249-4793-A75B-C260F467F587
P2860
Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Antiepileptogenesis and seizur ...... analysis of controlled trials.
@ast
Antiepileptogenesis and seizur ...... analysis of controlled trials.
@en
Antiepileptogenesis and seizur ...... analysis of controlled trials.
@nl
type
label
Antiepileptogenesis and seizur ...... analysis of controlled trials.
@ast
Antiepileptogenesis and seizur ...... analysis of controlled trials.
@en
Antiepileptogenesis and seizur ...... analysis of controlled trials.
@nl
prefLabel
Antiepileptogenesis and seizur ...... analysis of controlled trials.
@ast
Antiepileptogenesis and seizur ...... analysis of controlled trials.
@en
Antiepileptogenesis and seizur ...... analysis of controlled trials.
@nl
P2860
P1433
P1476
Antiepileptogenesis and seizur ...... analysis of controlled trials.
@en
P2093
P2860
P304
P356
10.1046/J.1528-1157.2001.28900.X
P577
2001-04-01T00:00:00Z